- ¥75bn
- ¥59bn
- ¥610bn
Brief: Vital Ksk Holdings Inc - To Buy Back Up To 4.13% Of Shares Worth 4 Billion Yen
Table: Vital KSK Holdings -2025/26 group results
Table: Vital KSK Holdings -2025/26 parent results
Table: Vital KSK Holdings - 9-MTH group results
Table: Vital KSK Holdings - 6-MTH group results
Table: Vital KSK Holdings -Q1 group results
Table: Vital KSK Holdings -2024/25 parent results
Table: Vital KSK Holdings -2024/25 group results
Brief: Vital KSK Holdings Inc - Conclusion Of Exclusive License Agreement Of Shield Therapeutics PLC's Iron Deficiency Treatment By Consolidated Subsidiary
Table: Vital KSK Holdings -2024/25 div forecast
Table: Vital KSK Holdings -2024/25 group forecast
Table: Vital KSK Holdings - 9-MTH group results
Table: Vital KSK Holdings -Q1 group results
Table: Vital KSK Holdings -2023/24 parent results
Table: Vital KSK Holdings -2023/24 group results
Brief: Vital KSK Holdings Inc - To Buy Back Up To 3.98% Own Shares Worth 3 Billion Yen
Table: Vital KSK Holdings -2023/24 group results
Table: Vital KSK Holdings -2023/24 parent results
Table: Vital KSK Holdings -2023/24 div forecast